<DOC>
	<DOCNO>NCT00468975</DOCNO>
	<brief_summary>A study determine ability different dose PF-610,355 open airway asthmatic patient comparison placebo market drug also open airway asthmatic patient .</brief_summary>
	<brief_title>A Blinded Study To Examine The Ability Of PF-610,355 To Open The Airways In Asthmatic Patients .</brief_title>
	<detailed_description />
	<mesh_term>Salmeterol Xinafoate</mesh_term>
	<criteria>Reversible asthmatic patient ( &gt; 15 % increase FEV1 follow 200ug salbutamol ) . FEV1 great equal 60 % predict Stable disease least previous 3 month Subjects require rescue medication great 2 occasion 72 hour prior screen Subjects history pulmonary disease asthma .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2010</verification_date>
</DOC>